Updated:
O2h Ventures
o2h ventures is an S/EIS fund focused on seeding early stage biotech therapeutics and related AI opportunities. It has a track record of nurturing and...
O2h Ventures
o2h ventures is an S/EIS fund focused on seeding early stage biotech therapeutics and related AI opportunities. It has a track record of nurturing and investing in emerging life science and tech companies. It invests in the growth potential of UK life science and AI.
General information
Firm type
Venture Capital
Year founded
2018
Location
Region
Europe
Country
United Kingdom
City
Cambridge
Corporate office
Mill SciTech Park, Mill Lane, Hauxton, Cambridge CB22 5HX, United Kingdom
Additional offices
Ahmedabad, India · Cambridge, MA, United States
Principals
Sunil Shah
CEO - o2h Ventures and Co-founder - o2h discovery
Prashant Shah
CEO - o2h co-work labs and co-founder - o2h group
Andy Morley
Chief Scientific Officer
Sector focus
Frequently asked questions
Who makes investment decisions at o2h Ventures?
Sunil Shah, CEO of o2h Ventures and co-founder of the o2h group, leads investment activities. Andy Morley, Chief Scientific Officer, also leads scientific evaluations for investments and provides strategic support across portfolio projects.
How is o2h Ventures related to the broader o2h group?
O2h Ventures is the investment fund arm of o2h group, which is organized into six symbiotic verticals. These include o2h discovery (a drug discovery services platform), o2h technology (custom software development), o2h therapeutics (newco co-curation and spin-outs), o2h co-work labs, and o2h community. The group structure allows the venture arm to co-create and co-invest alongside portfolio companies using in-house expertise.
Does o2h Ventures participate in direct deals or fund commitments?
O2h Ventures focuses on direct, early-stage equity investments in biotech therapeutics and related AI companies. It operates through a UK S/EIS fund structure designed to seed emerging life science and technology opportunities. The firm has not publicly disclosed any fund-of-fund commitments or secondary market activity.
Does o2h maintain research operations outside the UK?
Yes. O2h group is co-located in Cambridge, UK, and Ahmedabad, India. Its drug discovery platform operates from both locations, and the primary chemistry and biology service capabilities are heavily integrated with the Ahmedabad site. A small US presence is also listed in Cambridge, Massachusetts.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: